Combining anti tumor drugs with chemo may improve rare children's cancer outcomes Anshika Mishra11 Jan 2024 9:00 AM ISTChildren who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumour drugs as well...
Pfizer-Genmab Tivdak application accepted for priority review by USFDA for cervical cancer Ruchika Sharma10 Jan 2024 12:30 PM ISTNew York: Pfizer Inc. and Genmab A/S have announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental...
Researchers identify why cancer immunotherapy can cause colitis Dr. Kamal Kant Kohli9 Jan 2024 9:45 AM ISTResearchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with...
Journal Club Presentation- WHO Classification of bone tumors (fifth edition)- Ft. Dr Sonal Saran Dr. Nandita Mohan9 Jan 2024 9:30 AM ISTA recent review article was published in the Indian Journal of Musculoskeletal Radiology by Scientific Scholar titled "World Health Organization...
18F-FDG-PET/CT helps in prediction of brain metastasis in melanoma patients Jacinthlyn Sylvia8 Jan 2024 3:00 AM ISTMalignant melanoma is known for its aggressive nature and disproportionately high mortality rate among skin-related malignancies and is the third most...
Boehringer Ingelheim, 3T Biosciences enter into second partnership for cancer immunotherapies Ruchika Sharma7 Jan 2024 10:00 AM ISTIngelheim: Boehringer Ingelheim and 3T Biosciences have announced they have entered into a new strategic collaboration and licensing agreement...
Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline Ruchika Sharma6 Jan 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...
Cancer drug holds hope for treating inflammatory diseases including gout and heart diseases Dr. Kamal Kant Kohli6 Jan 2024 10:30 AM ISTA cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including...
Is Radon linked to health condition other than lung cancer? Anshika Mishra6 Jan 2024 9:15 AM ISTRadon, a naturally occurring radioactive gas produced when metals like uranium or radium break down in rocks and soil, is a known cause of lung...
New PET tracer noninvasively identifies cancer gene mutation for more precise diagnosis and therapy Dr. Kamal Kant Kohli3 Jan 2024 11:30 PM ISTA novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for...
Trastuzumab deruxtecan: AstraZeneca India Pharma unveils HER-2 positive metastatic breast cancer therapy Ruchika Sharma3 Jan 2024 3:59 PM ISTNew Delhi: AstraZeneca India Pharma Ltd., a science-led biopharmaceutical company officially launched Trastuzumab deruxtecan, therapy tailored...
Liso-cel cost effective second-line treatment for common form of lymphoma Dr. Kamal Kant Kohli2 Jan 2024 6:00 AM ISTLisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat)...
